Company
Company
No. 6408 of 75986top 9%down 2039 places this week
4 direct links
In a group of 378 closely linked entities, around
Weighted by public relations with evidence, recomputed daily.
Who invests in, owns, acquires or finances whom, from the relations AiSeek holds with evidence.
Lines show that a relation exists and which way it points; their thickness carries no amount. Dots only move to show the direction.
Arrows show the direction of the relationship. Filter to focus on a business area.
bringing approved and near-approved rare and specialty disease medicines to underserved patient populations across Greater China, Southeast Asia, and the Gulf regions.View source
bringing approved and near-approved rare and specialty disease medicines to underserved patient populations across Greater China, Southeast Asia, and the Gulf regions.View source
Golden Age Health (GAH) is a Singapore-headquartered commercial platformView source
Yossi Ben Amram, former President EURAM at MSD, and Reda Rebib, former healthcare investor at EQT.View source
Yossi Ben Amram, former President EURAM at MSD, and Reda Rebib, former healthcare investor at EQT.View source
a Singapore-headquartered commercial platform for rare and specialty disease medicines in Greater China and Asia-Pacific.View source
The company was co-founded in 2023 by Michel VounatsosView source
Kos Biotechnology Partners as a strategic investorView source
today announced a strategic investment in Golden Age Health (GAH) through its inaugural fund, Kos BioVentures.View source
Showing 1 to 8 of 9
Read the assertion alongside its sources. Expand a row to inspect the evidence.
Yossi Ben Amram, former President EURAM at MSD, and Reda Rebib, former healthcare investor at EQT.
PR Newswire news releases · 2026-10-27 06:03
Yossi Ben Amram, former President EURAM at MSD, and Reda Rebib, former healthcare investor at EQT.View source
a Singapore-headquartered commercial platform for rare and specialty disease medicines in Greater China and Asia-Pacific.
PR Newswire news releases · 2026-10-27 06:03
a Singapore-headquartered commercial platform for rare and specialty disease medicines in Greater China and Asia-Pacific.View source
bringing approved and near-approved rare and specialty disease medicines to underserved patient populations across Greater China, Southeast Asia, and the Gulf regions.View source
The company was co-founded in 2023 by Michel Vounatsos
PR Newswire news releases · 2026-10-27 06:03
The company was co-founded in 2023 by Michel VounatsosView source
The company was co-founded in 2023 by Michel Vounatsos
PR Newswire news releases · 2026-10-27 06:03
The company was co-founded in 2023 by Michel VounatsosView source
Yossi Ben Amram, former President EURAM at MSD, and Reda Rebib, former healthcare investor at EQT.
PR Newswire news releases · 2026-10-27 06:03
Yossi Ben Amram, former President EURAM at MSD, and Reda Rebib, former healthcare investor at EQT.View source
a Singapore-headquartered commercial platform for rare and specialty disease medicines in Greater China and Asia-Pacific.
PR Newswire news releases · 2026-10-27 06:03
a Singapore-headquartered commercial platform for rare and specialty disease medicines in Greater China and Asia-Pacific.View source
Showing 1 to 6 of 10
Valuation data is available on Pro and Research.
Included in ProKnow a page of this company that matters, such as pricing, a changelog, terms or careers? Suggest it. We read every suggestion; a page we add is watched for everyone, and we only count a change when two looks in a row agree.
Not available: Company signals · Financials · Filings · Sites · Guidance